Evidence map›Paper›PMID 40321069›Full record

ArticleBrain and behavior2025

Differential Expression of LncRNA MIAT and Its Clinical Significance in Intracranial Aneurysms.

Fuquan Liu, Shuai Hao, Jingliyu Wang, Lei Chen, Ning Jiang, Laixing Liu, Xiangyi Wang

Abstract read
In one paragraph

Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fuquan LiuDepartment of Neurosurgery, Mental Health Institute of Inner Mongolia Autonomous Region, The Third Hospital of Inner Mongolia Autonomous Region, Hohhot, China.
Shuai HaoDepartment of Neurosurgery, Inner Mongolia Baogang Hospital, Baotou, China.
Jingliyu WangDepartment of Neurosurgery, Inner Mongolia Baogang Hospital, Baotou, China.
Lei ChenDepartment of Neurosurgery, Inner Mongolia Baogang Hospital, Baotou, China.
Ning JiangDepartment of Neurosurgery, Inner Mongolia Baogang Hospital, Baotou, China.
Laixing LiuDepartment of Neurosurgery, Inner Mongolia Baogang Hospital, Baotou, China.
Xiangyi WangDepartment of Neurosurgery, Mental Health Institute of Inner Mongolia Autonomous Region, The Third Hospital of Inner Mongolia Autonomous Region, Hohhot, China.ORCID https://orcid.org/0009-0009-1737-3026

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIntracranial aneurysm (IA) is characterized by localized dilation or ballooning of a blood vessel in the brain with life-threatening consequences. This study set out to investigate the value of Long noncoding RNA myocardial infarction associated transcript (LncRNA MIAT) in diagnosis, rupture prediction, and prognosis for IA patients.

methodsThe clinical characteristics of controls (100 cases) and IA patients, including 88 cases of ruptured IA (RIA) and 132 cases of unruptured IA (UIA), were analyzed using the chi-square test and t-test. MIAT expression in the serum was detected. The diagnostic efficacy of MIAT for IA was assessed through receiver operating characteristic (ROC) curve analysis. IA patients were categorized into low-expression and high-expression groups, and the correlation between MIAT expression and clinical indicators in IA patients was analyzed. The risk factors for IA rupture were analyzed. The correlation between MIAT expression and the overall survival of IA patients was assayed. The risk factors for poor prognosis in IA patients were analyzed.

resultsLncRNA MIAT was elevated in IA patients, with higher expression in RIA patients than in UIA patients. MIAT expression could distinguish between healthy control and IA patients (area under the curve, AUC = 0.794, cut-off value = 1.26, sensitivity = 68.64%, specificity = 83.00%, p < 0.001), healthy control and UIA patients (AUC = 0.782, cut-off value = 1.15, sensitivity = 75.76%, specificity = 68.00%, p < 0.001), and UIA patients and RIA patients (AUC = 0.690, cut-off value = 1.46, sensitivity = 76.14%, specificity = 68.94%, p < 0.001). MIAT expression was significantly associated with hypertension, IA location, and IA rupture status. MIAT was an independent risk factor for IA rupture. For every one-unit increase in the relative expression of MIAT, the risk of poor prognosis in IA patients increased by 2.415 times (p = 0.014, 95% CI: 1.192-4.890). MIAT expression was correlated with the overall survival of IA patients and IA rupture in UIA patients. MIAT was an independent risk factor for poor prognosis of IA patients. For every one-unit increase in the relative expression of MIAT, the risk of poor prognosis in IA patients increased by 2.415 times (p = 0.014, 95% CI: 1.192-4.890).

conclusionHighly expressed MIAT is an independent risk factor for poor prognosis of IA and can support IA diagnosis and rupture prediction.

Indexed as

Aneurysm, RupturedIntracranial AneurysmRNA, Long NoncodingAdultAgedBiomarkersClinical RelevanceFemaleHumansMaleMiddle AgedPrognosisRisk FactorsBiomarkersMiat long non-coding RNARNA, Long Noncodingintracranial aneurysmLncRNA MIATRIAROCserumUIA

Identifiers

PMID40321069
PMCPMC12050643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.